Stockreport

Akorn's stock soars after FDA approves ANDA for hypotrichosis eyelash treatment [MarketWatch]

AKORN  (AKRX) 
Last akorn earnings: 10/31 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.akorn.com
PDF Akorn's stock soars after FDA approves ANDA for hypotrichosis of eyelashes treatment Shares of Akorn Inc. AKRX, +2.22% ran up 13% in premarket trade Wednesday, puttin [Read more]